Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

AMPHOTERICIN B

AMPHOTERICIN B

Standard Dose
50MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview AMPHOTERICIN B is listed in Drugs@FDA under application 064141 (ANDA).

Marketing status: Discontinued Active ingredient AMPHOTERICIN B Form and strength INJECTABLE;INJECTION - 50MG/VIAL Sponsor ABBOTT Submission history Latest submission status date: 2001-02-14 00:00:00.

Structured Monograph

Clinical summary

Approval overview AMPHOTERICIN B is listed in Drugs@FDA under application 064141 (ANDA). Marketing status: Discontinued Active ingredient AMPHOTERICIN B Form and strength INJECTABLE;INJECTION - 50MG/VIAL Sponsor ABBOTT Submission history Latest submission status date: 2001-02-14 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.